Immediate procedural and long-term clinical outcomes following drug-eluting stent implantation to ostial saphenous vein graft lesions

References

• Reeder GS, Bresnahan JF, Holmes DR, Jr, Mock MB, Orszulak TA, Smith HC, et al. Angioplasty for aorto-coronary bypass graft stenosis. Mayo Clin Proc. 1986; 61: 14–9
   PubMedGoogle Scholar
• DeFeyter PJ, VanSuylen RJ, DeJaegere PPT, Topol EJ, Serruys PW. Balloon angioplasty for the treatment of lesions in saphenous vein grafts. J Am Coll Cardiol. 1993; 7: 1539–49
   Google Scholar
• Abdel-Meguid AE, Whitlow PL, Simpfendorfer C, Sapp SK, Franco I, Ellis SG, et al. Percutaneous revascularization of ostial saphenous vein graft stenoses. J Am Coll Cardiol. 1995; 26: 955–60
   PubMedGoogle Scholar
• Rechavia E, Litvack F, Macko G, Eigler NL. Stent implantation of saphenous vein graft aorto-ostial lesions in patients with unstable ischemic syndromes: immediate angiographic results and long-term clinical outcome. J Am Coll Cardiol. 1995; 25: 866–70
   PubMedGoogle Scholar
• Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002; 346: 1773–80
   PubMed Web of Science ®Google Scholar
• Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349: 1315–23
   PubMed Web of Science ®Google Scholar
• Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003; 107: 38–42
   PubMed Web of Science ®Google Scholar
• Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788–94
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004; 350: 221–31
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 2004; 109: 1942–7
   PubMed Web of Science ®Google Scholar
• Ge L, Iakovou I, Sangiorgi GM, Chieffo A, Melzi G, Cosgrave J, et al. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. J Am Coll Cardiol. 2005; 45: 989–94
   PubMedGoogle Scholar
• Iakovou I, Ge L, Michev I, Sangiorgi GM, Montorfano M, Airoldi F, et al. Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions. J Am Coll Cardiol. 2004; 44: 967–71
   PubMed Web of Science ®Google Scholar
• Park DW, Hong MK, Suh IW, Hwang ES, Lee SW, Jeong YH, et al. Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease. Am J Cardiol. 2007; 99: 760–5
   PubMedGoogle Scholar
• Ellis SG, Brener SJ, DeLuca S, Tuzcu EM, Raymond RE, Whitlow PL, et al. Late myocardial ischemic events after saphenous vein graft intervention–importance of initially “non-significant” vein graft lesions. Am J Cardiol. 1997; 79: 1460–4
   PubMedGoogle Scholar
• Keeley EC, Velez CA, O'Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001; 38: 659–65
   PubMed Web of Science ®Google Scholar
• Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, et al. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: Results from the randomized delayed rrisc trial. J Am Coll Cardiol. 2007; 50: 261–267
   PubMed Web of Science ®Google Scholar
• Price MJ, Sawhney N, Kao JA, Madrid A, Schatz RA, Teirstein PS. Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions. Catheter Cardiovasc Intervent. 2005; 65: 208–11
   PubMedGoogle Scholar